Evidence map›Paper›PMID 10627494›Full record

ReviewClinical microbiology reviews2000

Potential role of phospholipases in virulence and fungal pathogenesis.

M A Ghannoum

Open access · bronzeAbstract readReview
In one paragraph

Review in Clinical microbiology reviews, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 251 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
251citing papers in PubMed, 2 pooled it
13.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

251 citing papers in PubMed, 2 syntheses or guidelines pooled it, 659 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Microbiology and molecular biology reviews : MMBR · 2026
    Review
  7. Genomic Insights ofOpen forum infectious diseases · 2026
    Review
  8. Antifungal activity of the culture filtrate ofFrontiers in microbiology · 2026
    Article
  9. Review
  10. Animals : an open access journal from MDPI · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Virulence Factors and Molecular Identification ofJournal of fungi (Basel, Switzerland) · 2025
    Article
  17. Biology · 2025
    Article
  18. Article
  19. Review
  20. Microorganisms · 2025
    Review

191 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

M A GhannoumCenter for Medical Mycology, Mycology Reference Laboratory, University Hospitals of Cleveland, and Department of Dermatology, Case Western Reserve University, Cleveland, Ohio 44106-5028, USA. mag3@po.cwru.edu
Case Western Reserve University · US

Funding

PHOSPHOLIPASES AND THE VIRULENCE OF C ALBICANSR01AI035097 · NIAID · LA BIOMED RES INST/ HARBOR UCLA MED CTR · PI GHANNOUM, MAHMOUD A · 1995 to 2009
$2.6M
NIAID NIH HHS AI35097NIAID NIH HHS R01 AI035097
6 · The paper itself

Abstract

Microbial pathogens use a number of genetic strategies to invade the host and cause infection. These common themes are found throughout microbial systems. Secretion of enzymes, such as phospholipase, has been proposed as one of these themes that are used by bacteria, parasites, and pathogenic fungi. The role of extracellular phospholipase as a potential virulence factor in pathogenic fungi, including Candida albicans, Cryptococcus neoformans, and Aspergillus, has gained credence recently. In this review, data implicating phospholipase as a virulence factor in C. albicans, Candida glabrata, C. neoformans, and A. fumigatus are presented. A detailed description of the molecular and biochemical approaches used to more definitively delineate the role of phospholipase in the virulence of C. albicans is also covered. These approaches resulted in cloning of three genes encoding candidal phospholipases (caPLP1, caPLB2, and PLD). By using targeted gene disruption, C. albicans null mutants that failed to secrete phospholipase B, encoded by caPLB1, were constructed. When these isogenic strain pairs were tested in two clinically relevant murine models of candidiasis, deletion of caPLB1 was shown to lead to attenuation of candidal virulence. Importantly, immunogold electron microscopy studies showed that C. albicans secretes this enzyme during the infectious process. These data indicate that phospholipase B is essential for candidal virulence. Although the mechanism(s) through which phospholipase modulates fungal virulence is still under investigations, early data suggest that direct host cell damage and lysis are the main mechanisms contributing to fungal virulence. Since the importance of phospholipases in fungal virulence is already known, the next challenge will be to utilize these lytic enzymes as therapeutic and diagnostic targets.

Indexed as

Amino Acid SequenceBacteriaFungiHumansMolecular Sequence DataMycosesPhospholipasesVirulencePhospholipases

Identifiers

PMID10627494
PMCPMC88936
OpenAlexW2143326683

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.